DHEA, Pregnenolone, and 7-Keto DHEA (2026): The Hormone-Precursor Supplement Cluster — What the RCT Evidence Shows, Real Deficiency Indications, the Side-Effect Profile, and Why 21 Products in Our Catalog Cap at Standard

September 6, 2026

TL;DR — the bottom line

DHEA and pregnenolone are hormone precursors with real but narrow evidence. They are not "gentle natural hormone support" — they are steroids sold over-the-counter, with androgenic and estrogenic conversion effects.

DHEA (dehydroepiandrosterone) is the most-abundant adrenal steroid in the human body. It naturally declines from a peak in the 20s to roughly 30% of that by age 70 — which is what drives the "anti-aging" marketing category. There is real RCT evidence for DHEA in specific indications: adrenal insufficiency (Arlt 1999), post-menopausal wellbeing and bone density (Baulieu 2000 DHEAge), and midlife-onset depression in specific patient subsets (Bloch 1999). Pregnenolone (upstream of DHEA in the steroid biosynthesis pathway) has smaller RCT support for cognition and schizophrenia adjunct treatment. But this is hormone territory — not vitamin territory — and the safety framing is different.

21 DHEA / pregnenolone / 7-keto products in the Vyvata catalog. Top cluster at 62-65 Standard. Zero Verified, zero Elite.
DHEA is banned by WADA for competitive athletes and prohibited by the NCAA, most professional sports, and Olympic testing bodies.
Third-party testing surveys have repeatedly found OTC DHEA products under-dosed or contaminated — sometimes containing 0-160% of label claim (Parasrampuria 1998, Consumer Lab surveys).
Androgenic side effects (acne, hair loss, voice changes) are documented in women. Estrogenic conversion (via aromatization to estradiol) is documented in both sexes and is dose- and metabolism-dependent.
This category is not a general-population supplement recommendation. It is a targeted intervention with specific indications and a real side effect profile.

⚠ Read this before anything else — who should NOT take DHEA or pregnenolone

DHEA and pregnenolone are steroids. Some people should not take them at any dose, over-the-counter or not.

Anyone with a personal or family history of hormone-sensitive cancer — breast, ovarian, uterine, or prostate. DHEA aromatizes to estradiol and can convert to testosterone downstream; both pathways carry potential to stimulate hormone-sensitive tissue growth.
Anyone under age 30 without a diagnosed clinical indication. Endogenous DHEA in a 25-year-old is at physiological peak — supplementing on top of that is pushing a lever the body is already fully engaged with. There is no evidence supporting anti-aging benefit in that age group.
Anyone competing in a WADA-tested sport, NCAA sport, or drug-tested professional league. DHEA will trigger a positive urine test.
Pregnant or breastfeeding women. Fetal exposure to androgens can cause virilization; DHEA is contraindicated.
Anyone taking prescription hormone therapy without their prescribing endocrinologist's oversight. Interactions with estrogen therapy, testosterone therapy, and thyroid medication are documented.
Anyone with active mood-related psychiatric illness that is not stable — DHEA has activating effects in some patients and has been associated with mania induction in bipolar-spectrum patients.

This article is educational content about supplement scoring and evidence. It is not medical advice. If you are considering hormone supplementation, get a baseline hormone panel (total testosterone, free testosterone, estradiol, DHEA-S, SHBG at minimum) and discuss with a licensed clinician — ideally an endocrinologist.

Section 1 — What DHEA is, biochemically

Dehydroepiandrosterone (DHEA) is a C19 steroid produced primarily by the adrenal cortex, with smaller amounts from the gonads and brain. It circulates predominantly as its sulfate ester (DHEA-S). DHEA is a steroid hormone precursor — it can be converted downstream to androstenedione, testosterone, dihydrotestosterone, and estradiol depending on tissue-specific enzyme expression and individual metabolism.

Two facts drive the entire marketing category:

Fact #1 — DHEA declines with age

Endogenous DHEA-S peaks around ages 20-30 and declines to roughly 20-30% of peak by age 70-80. This is one of the most consistent age-related endocrine changes. It's what "anti-aging" marketing latches onto: "if you restore the youthful level, you restore youthful function."

The subtlety: correlation between DHEA level and any specific clinical outcome (cognition, mood, muscle mass, sexual function) is inconsistent across studies. Restoring DHEA to youthful levels via supplementation does not reliably restore youthful function on those metrics.

Ravaglia G, Forti P, Maioli F, et al. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. The Journal of Clinical Endocrinology & Metabolism 1996;81(3):1173-1178.

Fact #2 — DHEA is available OTC in the United States, by prescription almost everywhere else

DHEA was grandfathered into DSHEA 1994 as a dietary supplement in the United States because it was on the market prior to 1994. In Canada, the UK, Australia, and most of Europe, DHEA is prescription-only. This regulatory anomaly is why US consumers have direct OTC access to a steroid that most of the developed world considers a controlled substance.

Practical implication: the fact that you can buy DHEA on Amazon is not a signal that it is a benign wellness supplement. It is a signal that DSHEA has a specific grandfathering carve-out for it.

Section 2 — The RCT evidence, indication by indication

Adrenal insufficiency — the strongest indication (Arlt 1999)

Arlt et al. 1999 (New England Journal of Medicine) — 24 women with adrenal insufficiency (Addison's disease or hypopituitarism) randomized to DHEA 50 mg/day vs placebo. DHEA improved wellbeing (measured on standardized scales), sexual function, and body composition versus placebo. This is the foundational "DHEA is a legitimate replacement therapy" evidence.

Important: this indication is for patients with a diagnosed clinical deficiency, not general-population aging. Adrenal insufficiency is a specific clinical condition requiring endocrinologist involvement.

Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine 1999;341(14):1013-1020.

Post-menopausal wellbeing and bone — Baulieu 2000 DHEAge study

Baulieu et al. 2000 (PNAS) — DHEAge study, one-year DHEA 50 mg/day vs placebo in 280 healthy men and women aged 60-79. Bone mineral density improved modestly in women; libido and skin quality improved; effects on cognition and mood were smaller and mixed. This is the most-cited "DHEA for aging" trial.

Interpretation: modest benefits in a specific subset (older women), at a specific dose (50 mg/day), over a specific duration (12 months). Not a universal "anti-aging" mandate — a specific, replicable effect in one demographic.

Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proceedings of the National Academy of Sciences 2000;97(8):4279-4284.

Midlife depression — Bloch 1999 / Wolkowitz 1999

Multiple small RCTs (Bloch 1999 Biological Psychiatry, Wolkowitz 1999 American Journal of Psychiatry) tested DHEA 30-90 mg/day in midlife-onset depression. Effect sizes on depression rating scales were modest but statistically significant in the treatment arms. The mechanism is not fully worked out — proposed to involve neurosteroid effects at GABA and NMDA receptors plus downstream androgen/estrogen contributions.

Reproducibility across larger trials has been more mixed. This is not on the level of Akhondzadeh 2005 for saffron — smaller effect sizes, more heterogeneity.

Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR. Dehydroepiandrosterone treatment of midlife dysthymia. Biological Psychiatry 1999;45(12):1533-1541. · Wolkowitz OM, Reus VI, Keebler A, et al. Double-blind treatment of major depression with dehydroepiandrosterone. American Journal of Psychiatry 1999;156(4):646-649.

Pregnenolone — smaller evidence base, cognitive and psychiatric indications

Pregnenolone is upstream of DHEA in steroid biosynthesis. It converts to progesterone, DHEA, and downstream to sex steroids depending on tissue-specific enzymes. Marx et al. 2011 (Neuropsychopharmacology) tested pregnenolone 500 mg/day as adjunct to antipsychotics in schizophrenia patients — showed cognitive improvements. Vallée 2020 reviewed pregnenolone for cannabis-use disorder with modest effect.

The general-population "pregnenolone for memory / brain fog" marketing is not well-supported at the RCT level. The evidence base is narrower and more specific than most product marketing implies.

Marx CE, Keefe RS, Buchanan RW, et al. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology 2009;34(8):1885-1903.

7-Keto DHEA — a metabolite that doesn't convert to sex hormones

7-Keto DHEA (3-acetyl-7-oxo-DHEA) is a naturally-occurring DHEA metabolite that does not convert to androgens or estrogens. Marketed primarily for thermogenesis and weight loss. Kalman 2000 and others reported modest metabolic effects in small RCTs; the evidence base is thinner and effect sizes are more modest than the marketing implies. The safety profile appears cleaner than parent DHEA specifically because sex-hormone conversion doesn't happen.

Kalman DS, Colker CM, Swain MA, Torina GC, Shi Q. A randomized, double-blind, placebo-controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweight adults. Current Therapeutic Research 2000;61(7):435-442.

Section 3 — The side-effect profile the marketing doesn't emphasize

Androgenic side effects (dose-dependent, more prominent in women)

DHEA converts downstream to androgens (testosterone, dihydrotestosterone). At doses above about 25 mg/day, women can experience acne, hirsutism (increased body/facial hair), scalp hair thinning (androgenic alopecia), voice deepening, and menstrual cycle changes. These effects are dose-dependent and can be substantially reversible if the supplement is stopped early enough — but voice changes may not fully reverse. Men can experience prostate-related concerns, though the evidence base for prostate cancer risk from DHEA supplementation specifically is unclear.

Estrogenic conversion (individual-metabolism-dependent)

DHEA aromatizes to estradiol, particularly in adipose tissue. Individual variability in aromatase enzyme expression means some users see meaningful estradiol increases at modest DHEA doses; others do not. In men, this can present as gynecomastia, fluid retention, and mood changes. In post-menopausal women, this can present as breast tenderness and endometrial changes.

OTC DHEA products are frequently under-dosed or contaminated

Parasrampuria et al. 1998 (JAMA) tested 16 commercial DHEA products and found actual DHEA content ranging from 0% to 160% of label claim. Consumer Lab surveys have repeatedly documented similar variance in modern products. This is not a category where you should assume a 25 mg label means 25 mg in the capsule — third-party testing is essential, and products that publish per-batch Certificates of Analysis are meaningfully more trustworthy than those that don't.

Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998;280(18):1565.

Section 4 — The 21 products in our catalog

DHEA / pregnenolone / 7-keto products ranked

Score	Tier	Product	Notes
65	Standard	21st Century® DHEA 25 mg — 90 caps	Reference-dose DHEA at 25 mg (modest end of studied range). Established manufacturer. Standard-tier ceiling on third-party CoA testing.
62	Standard	Portions Master DHEA Hormonal Support (100 ct)	Reference dose format at value pricing.
60	Standard	Generic DHEA	Standard DHEA capsule format.
58	Standard	7-Keto DHEA	Non-sex-hormone metabolite variant. Cleaner side-effect profile than parent DHEA.
58	Standard	Pregnenolone (multiple products in this tier)	Reference-dose pregnenolone at typical labels. Studied doses in the RCT literature range 10-500 mg depending on indication.
58	Standard	NusaPure Pregnenolone Micronized 100 mg × 200 caps	Micronization improves bioavailability. Value pricing.
58	Rejected	Ortho Molecular Products DHEA 25 mg	Practitioner-channel brand — Rejected on the specific reasoning documented in the per-product scoring.
54	Rejected	NusaPure DHEA 100 mg × 200 caps	100 mg per capsule dose is at the higher end of the RCT literature and beyond what most general-population users should take without endocrinologist oversight.
44-50	Rejected	Force Factor DHEA 50 mg, Nature's Truth DHEA 25 mg, others	Various rubric flags — some are dose-adequacy (products at 100 mg per capsule without dose-splitting guidance), some are marketing-claim flags, some are third-party testing gaps.

Why does the whole category cap at Standard?

Three consistent transparency gaps prevent any DHEA/pregnenolone product in our current catalog from clearing Verified:

Third-party per-batch Certificate of Analysis — given Parasrampuria 1998 and repeated Consumer Lab surveys documenting label-claim variance in this specific category, per-batch CoA testing is a meaningful quality signal that most consumer products don't publish.
Long-term safety documentation — most RCTs are 6-12 months. Multi-year daily use of hormone precursors is not well-characterized in the general population.
Clinical-use documentation — because DHEA has specific indications (adrenal insufficiency, post-menopausal wellbeing, midlife depression subsets), products would score higher if they clearly documented "this is intended for the following specific indication, verified by clinician" rather than being sold as general-population anti-aging.

Section 5 — If you're considering DHEA or pregnenolone, do this instead of guessing

The workup that separates evidence-anchored use from Reddit-anchored use

Get baseline hormone labs before starting. Minimum panel: total testosterone, free testosterone, DHEA-S, estradiol, sex hormone binding globulin (SHBG). For women, include a menopause-status marker (FSH). This is $100-200 out-of-pocket at a Quest / LabCorp direct-to-consumer draw, or covered under most insurance with a primary care order.
Interpret the results with a clinician. A DHEA-S of 300 μg/dL is at the physiological ceiling for a 40-year-old and does not warrant supplementation. A DHEA-S of 30 μg/dL is in the low range for an 80-year-old and can plausibly benefit from replacement.
Start low. 10-25 mg/day is a reasonable starting dose for most adults. 50 mg/day is the DHEAge study dose and Arlt 1999 dose but should not be the initial dose without clinician guidance.
Recheck labs at 3 months. Verify the DHEA and downstream estradiol / testosterone are moving into physiological ranges, not above them.
Reassess symptoms honestly. If wellbeing, mood, or the specific indication you were targeting has not measurably improved at 3-6 months, the intervention is not working for you. This is diagnostic information, not a reason to escalate the dose.
Choose a product with third-party testing. Given the label-claim variance documented in this specific category, testing is not optional.

Section 6 — What we don't know

Does long-term daily DHEA supplementation increase hormone-sensitive cancer risk?

Long-term daily use has not been meaningfully studied in the general population for cancer endpoints. Given aromatization to estradiol and downstream androgen conversion, the theoretical risk is not zero. This is why anyone with personal or family history of hormone-sensitive cancer should not take DHEA.

Is DHEA useful for improving IVF outcomes in women with diminished ovarian reserve?

The evidence is mixed. Some studies (Wiser 2010, Barad 2007) suggest DHEA improves oocyte yield and pregnancy rates in DOR. Meta-analyses have been inconsistent. This is a reproductive-endocrinology decision that belongs with your fertility specialist, not with the OTC supplement aisle.

Does pregnenolone work for "brain fog" and general cognitive support in healthy adults?

Not well-supported by RCT evidence in healthy adults. Marx 2011 was in schizophrenia patients; other cognitive trials have been small. The general-population "pregnenolone for memory" positioning outruns the evidence base.

Is 7-keto DHEA a meaningful weight-loss intervention?

Effect sizes in the published RCTs are modest — a few pounds over 8-12 weeks at 100-200 mg/day, plus some metabolic-rate signals. This is not a substitute for the fundamentals (caloric intake, protein intake, resistance training, sleep). The marketing frequently oversells this.

Frequently asked questions

Is DHEA a testosterone booster?

Sort of, but not the way the marketing implies. DHEA is a precursor that can convert to testosterone downstream — but it also converts to estradiol, and the direction depends on individual metabolism. In young men with normal testosterone, DHEA supplementation does not reliably raise testosterone into a beneficial range and can raise estradiol. It is not a substitute for a proper testosterone replacement protocol when clinically indicated.

Can I take DHEA if I'm trying to get pregnant?

Discuss with your fertility specialist. Some reproductive endocrinologists use DHEA in specific fertility protocols for diminished ovarian reserve. Others do not. This is not a decision to make from a supplement label.

Will DHEA give me acne?

Possibly, especially at doses above 25 mg/day. Acne is one of the more common dose-dependent side effects, particularly in women. If acne appears after starting DHEA, that is a signal to reduce the dose or stop.

Is pregnenolone safer than DHEA?

Not clearly. Pregnenolone is upstream of DHEA in the biosynthesis pathway, and it can convert to the same downstream steroids. The RCT safety evidence base is smaller than DHEA's, so "less studied" is not the same as "safer."

Can I take DHEA with an SSRI or thyroid medication?

Not without your prescriber's knowledge. DHEA can affect thyroid-hormone binding globulin and has been associated with mood changes in some patients on SSRIs. Interactions are individual and warrant clinician oversight.

Should healthy 30-year-olds take DHEA?

No, based on the current evidence. A healthy 30-year-old has physiologically-normal DHEA levels. Supplementing on top of that has no demonstrated benefit and carries the same side-effect risk as at any age.

Where can I read your scoring methodology?

Our 6-dimension rubric is applied uniformly to every supplement in the catalog. The scoring-integrity policy documents the rules that prevent score manipulation. Every scoring commit lands in the public GitHub repository with evidence artifacts.

Item added to your cart